The DOI matches its Crossref record.
Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
Abstract
We report 17 cytopenic patients with myelodysplastic syndrome (MDS) of refractory anaemia (RA) subtype with hyper‐, normo‐ or hypo‐cellular bone marrow (BM), who were treated with cyclosporin A (CyA). Substantial haematological response was observed in 14 patients (82%): their anaemia improved and all transfusion‐dependent patients achieved transfusion independence. Complete trilineage recovery was observed in four patients (23%). The CyA therapy has not yet failed in any of the 14 successfully treated patients during follow‐up times ranging from 5 to 30 months. CyA was well tolerated in 14 patients; serious side‐effects required termination of the therapy in three patients in whom the blood count rapidly deteriorated to former levels upon cessation of therapy. Two patients benefited from a combination therapy of CyA and erythropoietin. Six patients experienced various autoimmune phenomena. CyA could thus offer an alternative treatment for certain MDS patients with RA regardless of hyper‐, normo‐ or hypo‐cellularity of bone marrow (BM). The mechanism of the beneficial effect of CyA is discussed and remains the subject of an ongoing study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Heaney, M. L., & Golde, D. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402107 · Cited by 388
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
Bowen, D., Culligan, D., Jowitt, S., Kelsey, S., Mufti, G., Oscier, D., Parker, J., & of the UK MDS Guidelines Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03907.x · Cited by 298
Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes
Dunn, D. E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S. W., Kirby, M. R., Kumar, M. S. A., Rosenfeld, S., & Young, N. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-6-199909210-00002 · Cited by 279
Saunthararajah, Y., Nakamura, R., Nam, J.-M., Robyn, J., Loberiza, F., Maciejewski, J. P., Simonis, T., Molldrem, J., Young, N. S., & Barrett, A. J. (2002) · Blood · doi:10.1182/blood.v100.5.1570.h81702001570_1570_1574 · Cited by 273
Barrett, J., Saunthararajah, Y., & Molldrem, J. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90027-1 · Cited by 207
Metadata
- Authors
- JonÁšovÁ, A., NeuwirtovÁ, R., ČermÁk, J., VozobulovÁ, V., MocikovÁ, K., ŠiškovÁ, M., & HochovÁ, I.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1998-02
- Volume
- 100
- Issue
- 2
- Pages
- 304-309
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1519963426
- Cited by
- 211
- References
- 0
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. https://app.cochat.ai/papers/10.1046/j.1365-2141.1998.00551.x
- The paper
- JonÁšovÁ, A., NeuwirtovÁ, R., ČermÁk, J., VozobulovÁ, V., MocikovÁ, K., ŠiškovÁ, M., & HochovÁ, I. (1998). Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1998.00551.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.